David Wilson is an Anglo-Australian business and tech specialist whose experience in journalism spans two decades. His stories have run everywhere from the South China Morning Post to Slate and The New York Times. In the 20-teens he ran a successful rehousing campaign for an extended Vietnamese family of slum-dwellers. In his spare time, he does strength training and hangs out with domestic cats.

Articles by David Wilson

Pharma Giant GSK and mRNA Biotech CureVac Ink €1B Deal

Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal

Forbion Raises €185M to Fuel Late-Stage European Biotechs

Swiss Regenerative Medicine Biotech Closes €19M Series B

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II